Explore On-Demand Expert Webinars

Expand your clinical toolkit by exploring gut-directed hypnotherapy (GDH) as a primary, evidence-based intervention for Irritable Bowel Syndrome. This webinar shifts the focus from restrictive elimination diets to the science of Disorders of Gut–Brain Interaction, providing you with a clear understanding of how GDH modulates symptom pathways. Learn exactly how to integrate this potent tool into your practice to achieve superior, long-term patient outcomes without relying solely on dietary restriction.

Expand your clinical toolkit by exploring gut-directed hypnotherapy (GDH) as a primary, evidence-based intervention for Irritable Bowel Syndrome. This webinar shifts the focus from restrictive elimination diets to the science of Disorders of Gut–Brain Interaction, providing you with a clear understanding of how GDH modulates symptom pathways. Learn exactly how to integrate this potent tool into your practice to achieve superior, long-term patient outcomes without relying solely on dietary restriction.

Join us in discussing the pathology and clinical outcomes of a wide range of food/compound intolerance and how to safely treat them with enzyme therapy. Anouk Martini is a Registered Dietitian with over 5 years of experience at Intoleran. Passionate about empowering healthcare professionals, Anouk specialises in providing dietitians with accurate, evidence-based information to better support their clients with food intolerances. Her goal is to equip practitioners with the tools they need to deliver optimal care and improve patient outcomes.

Master the gold-standard RPAH Diagnostic Elimination Diet and Challenge Protocol to effectively identify and manage food chemical sensitivities. This webinar provides clinicians and students with a clear, evidence-based roadmap for investigating the role of salicylates, amines, glutamates, and additives in chronic urticaria, functional GI disorders, and migraines. Gain the practical expertise to guide patients through systematic elimination and reintroduction, ensuring accurate trigger identification and long-term symptom relief.

MASLD (Metabolic Associated Steatotic Liver Disease) is the leading cause of chronic liver diseases in North America and is positioned to be the primary indication for liver transplantation in the next 5-10 years. Major risk factors include metabolic syndrome, type II diabetes, obesity, visceral adiposity and diminished physical activity, among others. Despite trials that consistently demonstrate significant improvement in MASLD related fibrosis, steatohepatitis and steatosis with 5% or greater weight loss, achieving this and its maintenance is elusive for many.

Inflammatory Bowel Disease (IBD), which includes Crohn’s disease and ulcerative colitis, is a chronic inflammatory condition of the gastrointestinal tract which significantly affects quality of life. While there is no cure, dietary strategies, particularly the Mediterranean Diet, have emerged as powerful tools to help manage IBD. Patients adopting this diet may experience fewer flare-ups, improved gut microbiome, reduced inflammation, and overall enhanced well-being.

The low FODMAP diet is gaining recognition among consumers, and there are opportunities to communicate the scientific basis, specific intention, and appropriate implementation of the diet to ensure it achieves the clinical goal. In this webinar Kristen and Ijmeet cover the aetiology, diagnosis, and symptomology of IBS. In addition, the specific action of lactose, excess fructose, GOS, fructans, and polyols and their contributions to GI symptoms were reviewed.

In this webinar, Associate Professor Dr. Hannah Holscher examines the complex relationship between diet, the gut microbiome, and human health. The session explores how food processing – including factors like temperature and pH – alters nutrient bioavailability and influences microbial metabolism. Dr. Holscher discusses the fermentation of undigested fibres into beneficial short-chain fatty acids, as well as the direct and indirect impacts of dietary fats on microbiota through bile acid secretion.

Chronic constipation is a common condition affecting approximately 1 in every 10 individuals worldwide. While criteria exist for making the diagnosis, there are multiple different forms of constipation. In most instances, individuals will cycle through at least 3 over-the-counter medications before seeking medical care. Further care often includes using individual prescriptions or combination therapies. Despite the availability of medications to treat constipation, a significant percentage will fail to respond.

This webinar takes a deep dive into the role wheat plays in the symptoms of IBS. When one goes on a wheat or gluten free diet, gluten is not the only food component that is removed from the diet. Fructans, along with other compounds, also present in wheat, are reduced and thus may be responsible for symptom improvement.